CYLD mutations are linked to high PD-L1 expression in thymic carcinoma, and the downregulation of CYLD is associated with PD-L1 expression mediated by interferon-gamma in thymic epithelial tumor cell lines [134]. This evidence concerns the gene CD274 and thymic carcinoma.